Introduction
============

The *γ*-H2AX assay has been shown to be a reliable and sensitive indicator of radiation-induced DNA double-strand breaks ([@ref-17]; [@ref-9]). In addition, several *ex vivo* studies ([@ref-7]; [@ref-8]; [@ref-12]; [@ref-11]) have shown the potential of the *γ*-H2AX assay as a useful biodosimetry tool from hours to ∼3 days post exposure. The *γ*-H2AX assay can produce dose estimates within a few hours of receiving a blood sample ([@ref-15]; [@ref-1]) making it a good candidate for high throughput biodosimetry in the case of a mass casualty event. One option has been to develop fully automated systems such as the RABIT system ([@ref-5]; [@ref-18]) capable of processing several thousand samples a day. A drawback of this approach is that it requires highly sophisticated robotic equipment and tailored process control software, which may be unavailable to some laboratories. An alternative option to increase through-put is to have an assistance network of laboratories, such as those involved in the European funded MULTIBIODOSE and RENEB projects, and to reduce the processing time required for the *γ*-H2AX assay using routinely available equipment.

Here a method is presented for the assessment of *γ*-H2AX foci for biological dosimetry, that uses a lyse/fix buffer to lyse red blood cells and fix leukocytes in one step from small 'finger prick'-sized blood samples. Potentially, the 96-well plate-compatible lyse/fix method would be a faster and more scalable technique for high sample through-put compared to the routine protocol used to process samples for *γ*-H2AX foci scoring, which involves the isolation of lymphocytes from at least 2 ml of blood using Ficoll density gradient centrifugation with subsequent washing and fixation steps.

Materials and Methods
=====================

Blood sampling and irradiation
------------------------------

Heparinised venous blood was taken with written informed consent and the ethical approval of the Berkshire research ethics committee (Ref 09/H0505/87) from 17 healthy donors. Whole blood was placed into 15 ml centrifuge tubes, positioned inside a 22 mm polystyrene block with 8 mm Perspex, and sham-exposed or exposed to 0.5 or 1.0 Gy of 250 kVp X-rays (with a half-value layer of Cu/Al filtration) at a dose rate of 0.5 Gy/minute (min). Dosimetry was performed with a calibrated reference ionisation chamber for the exact exposure setup used. Exposures were always monitored using a calibrated UNIDOS E electrometer and 'in-beam' monitor ionisation chamber (all from PTW, Germany). Spatial dose uniformity was checked using Gafchromic EBT2 films (Vertec Scientific Ltd., UK). Following irradiation, the blood was held at 37°C for 0.5 or 1 h to simulate *in vivo* repair. Samples were then processed for the assessment of *γ*-H2AX foci by the routine histopaque or rapid lyse/fix method. A record was made of the time taken for each step in the process. To test the suitability of the lyse /fix method for biological dosimetry, samples were exposed to X-ray doses up to 4.3 Gy and incubated for 2 h at 37°C. Coded samples were processed using both methods, scored and used to produce estimates of dose.

Rapid 96 well lyse/fix method
-----------------------------

Aliquots of 90 µL whole blood were placed into a 96 deep well plate (\#FB58005; Fisher Scientific, UK). To each well, 1× lyse/fix buffer (\#558049; BD Biosciences, UK) pre-warmed to 37°C was added to give a dilution of 1:20, thoroughly mixed and incubated at 37°C for 14 min. After centrifugation at 250 g for 5 min the supernatant was removed using an 8 channel aspirator. Following two washes in cold phosphate buffered saline (PBS) the cell pellet was re-suspended in ∼50 µl of PBS. An aliquot of 25 µL per sample was spotted onto a teflon/silane coated 14-well slide (Tekdon Incorporated, USA) and the cells were allowed to adhere for ∼15 min. When the slides were almost dry they were placed in a moist camber and incubated in 0.5% Triton-X (Sigma, UK) in PBS for 5 min. The slides were then drained and incubated for 10 min in blocking solution (BS), containing 1% bovine serum albumin (Sigma, UK) in PBS. Once any excess liquid had been removed, 100 µL of mouse *γ*-H2AX antibody (\#613402; BioLegend, UK), diluted 1:500 in BS, was applied to each slide. After incubating the slides in the dark for 40 min at room temperature they were washed 3 times in BS. Slides were then incubated in the dark with 100 µL of goat anti-mouse AlexaFlour 488 secondary antibody (Abcam, UK), diluted 1:500 in BS, together with 0.2 µg/ml 4′,6-diamidino-2-phenylindole (DAPI) for 30 min at room temperature. Finally the slides were washed three times in PBS and mounted in Vectashield anti-fade solution (Vector Laboratories, UK). A detailed description of the lyse/fix protocol, sample requirements and materials can be found in [Supplemental Information 1](#supp-1){ref-type="supplementary-material"}.

Routine histopaque method
-------------------------

The histopaque method has been described in detail by [@ref-16]. In brief, 2 ml of whole blood was mixed 50:50 with PBS and layered onto 4 ml Histopaque 1077 (Sigma, UK) in 15 ml conical centrifuge tubes. After centrifugation at 1200 g for 5 min, the buffy coat layer was washed twice in PBS and the cell pellet re-suspended in ∼0.1 ml of PBS. 10 µL of the cell suspension was spotted onto a multi-well slide. Cells were allowed to adhere to the slide for ∼15 min and then fixed in 2% formaldehyde in PBS for 5 min, followed by 5 min in 0.25% Triton-X100 + 0.1% glycine in PBS. At this stage the blocking step and the immunostaining was carried out in the same manner as the lyse/fix method described above.

Manual scoring of *γ*-H2AX foci
-------------------------------

All the slides were examined at ×600 magnification using a Nikon Optiphot 2 fluorescence microscope, equipped with separate filters for DAPI and fluorescein isothiocyanate (FITC). Manual scoring was timed for three unirradiated and three 1 Gy/1 h incubated samples on slides produced by both processing methods. A total of 50 lymphocytes were scored per sample and the time taken to do this was recorded every ten cells. To ensure the lyse/fix processing itself did not affect foci levels, samples irradiated at 0.5 Gy/repair time 30 min and prepared using both protocols were used to assess the number of foci per cell seen in a panel of 17 donors. 50 lymphocytes were scored in each of the reference samples and the foci numbers were used to adjust the calibration coefficients and the associated standard errors ([@ref-16]) of the laboratory's calibration curve ([@ref-7]). Blood dose estimates for the unknown samples were produced by scoring up to 50 lymphocytes or 200 foci per sample.

Automated scoring of *γ*-H2AX foci
----------------------------------

The performance of automated scoring was also assessed on samples processed by the two methods. For each processing method and the two irradiation conditions, 10 fields of view were scored automatically. Maximum projection images of seven *z* planes at 1 µm step size were captured for *γ*-H2AX and DAPI staining (only one central plane imaged) using a ×40 objective. Foci analysis was performed with the TRI2 program, which contains batch processing functionality and automatic sorting of images. The method used for foci counting and analysis was the Compact Hough and Radial Map (CHARM) algorithm aimed at faint and ill-defined shapes ([@ref-2]). The foci analysis software has been fully described in [@ref-14].

Statistical analysis
--------------------

Mean foci yields and standard deviations were calculated. The Student's *t*-test was performed to compare foci yields. Linear regressions were performed using Minitab™ 15 to assess the accuracy of dose estimations using the two protocols. Constant coefficients were insignificant (*p* \> 0.4; *t*-test) for all regressions. Estimated slope coefficients are reported together with their associated standard errors.

Results and Discussion
======================

The time taken to process 16 samples using the lyse/fix protocol and 8 samples by the histopaque method is very similar, 179.5 min and 171 min respectively---see [Fig. 1](#fig-1){ref-type="fig"} which also shows the individual protocol steps. The time for each step in both protocols has been recorded and an estimate made of the timings for handling of 96 samples. Scaling up the timings for preparing 96 samples by the lyse/fix or histopaque method gives an increase in the estimated processing time of a factor of ∼1.4 (256 min total) and ∼2.5 (439 min total) respectively. Most of the difference between the two protocols is the time taken to process the samples through the first 3 steps. Provided that multi-channel pipettes and aspirators for liquid handling are used, one person could complete the first three steps of the lyse/fix protocol for 96 samples in 72 min. If one person were to process 96 samples by the histopaque method up to and including step 3 this would take more than three times as long (226 min). In reality, given the long processing time required for one person to get 96 samples to step 4 of the histopaque protocol, which may adversely affect the blood separation or lower foci levels, either several persons would need to work together or the samples be divided into batches. Assuming four batches of 24 samples each, the histopaque processing time for 96 samples would be 880 min (14.7 h) for one operator ([Fig. 1](#fig-1){ref-type="fig"}).

![Sample processing times for the lyse/fix versus the routine histopaque method for different numbers of samples.\
Steps 1--11: 1, lyse/fix or isolation; 2, washing; 3, transfer; 4, adhere; 5, permeabilise (and fixation for histopaque method); 6, blocking; 7, stain1; 8, wash; 9, stain2; 10, wash; 11, mount. Reported processing times are based on one timed experiment using 16 (lyse/fix) or 8 (histopaque method) samples and scaling estimates for the handling of 96 samples.](peerj-02-282-g001){#fig-1}

Usually in the routine histopaque protocol cell suspensions are spread onto individual slides, but for a large number of samples this would be time consuming. For the purposes of this comparison, cells prepared by both techniques were spotted onto 14-well slides. The time taken to complete steps 5 to 11 would be similar for both protocols, 169 (lyse/fix) and 198 min (histopaque). Multi-well slides also enable one person to carry out the protocol after lysis and fixation, as the time between the addition of a solution to the first well and the last is not so great as to adversely affect any step of the staining protocol. However, this is not the case for the histopaque protocol, which requires cells to be fixed after they have been placed on the slide, and this is a time critical step. Again, several persons would be needed to process all the slides together; alternatively they could be stained in batches by one person.

Histopaque separation of whole blood produces a cell suspension containing lymphocytes. In contrast, the lyse/fix protocol produces a cell suspension made up of lymphocytes and other white cell types, which can make foci analysis more challenging. [Figure 2](#fig-2){ref-type="fig"} shows images of one field of view of cells processed by the lyse/fix and histopaque methods from irradiated and unirradiated samples. By comparing the images it can be seen that the lyse/fix method gives fewer lymphocytes per field of view (i.e., round cells) and more debris. In addition the foci are not as clearly visible as in samples processed by the histopaque method. Despite differences in the appearance of samples produced by the two methods, manual scoring produced similar foci yields in lymphocytes from a panel of donors exposed to 0.5 Gy X-rays, as shown in [Fig. 3](#fig-3){ref-type="fig"}. Samples processed by the histopaque and lyse/fix method gave similar average foci counts of 6.83 ± 0.80 and 7.12 ± 0.51 respectively (*p* = 0.26). These values are consistent with previous studies ([@ref-7]; [@ref-4]; [@ref-13]).

![*γ*-H2AX foci in human blood leukocytes prepared with the lyse/fix or histopaque method.\
Fluorescence microscopic maximum projection images (×40 objective) show *γ*-H2AX foci (green) and DNA counterstain (blue) following exposure to 0 or 1 Gy X-rays and incubation for 1 h.](peerj-02-282-g002){#fig-2}

![Comparison of manual *γ*-H2AX foci counts.\
Different volunteer blood samples were processed by the lyse/fix or histopaque method following 0.5 Gy X-irradiation and 30 min incubation at 37°C.](peerj-02-282-g003){#fig-3}

In order to estimate the time required to analyse 96 samples, three slides for each processing method and dose point were scored. For each slide the time taken to score a batch of 10 cells was recorded and then repeated a further 4 times. The average time taken to score each batch of 10 cells from the three slides was then used to estimate the time it would take one person to score 20 cells from 96 samples. Previous work has demonstrated that scoring 20 cells can produce dose estimates that will reliably place samples into the correct exposure categories required for triage ([@ref-15]). As expected the mean time taken to score a 0 Gy sample is less than for a 1 Gy sample at 1 h post exposure for both preparation methods. However, for the 0 Gy sample the estimated time taken to score 20 cells in 96 samples prepared by the lyse/fix protocol was about twice as long as for those produced by the histopaque method ([Table 1](#table-1){ref-type="table"}). At the higher dose of 1 Gy the difference in scoring time between the two processing methods was not as great.

10.7717/peerj.282/table-1

###### Comparison of scoring times required for the lyse/fix and histopaque method.

Estimated time (in hours) needed for scoring 20 cells in 96 samples processed using the two different protocols.

![](peerj-02-282-g006)

               0 Gy    1 Gy + 1 h
  ------------ ------- ------------
  Lyse/fix     3.1 h   7 h
  Histopaque   1.5 h   6.1 h

Simply comparing the lyse/fix protocol with the histopaque method for processing and scoring all 96 samples suggests the time taken would be similar for both irradiation conditions, 7.4 h versus 8.8 h (unirradiated) and 11.3 h versus 14.4 h (irradiated) respectively. However, the histopaque protocol requires at least two people to achieve this compared to one for the lyse/fix method. A more realistic comparison involves the 96 samples being split into 4 batches for the histopaque method to be carried out by one person. When this is done the estimated time taken to process and score 96 samples by the histopaque method is 16.2 h (unirradiated) and 20.8 h (irradiated). This is approximately twice the time required for sample processing and scoring using the lyse/fix protocol. Furthermore, reagent costs for the histopaque method (∼£116/96 samples) are twice as high as those for the lyse/fix protocol (∼£57/96 samples).

The more challenging analysis procedure required for samples produced by the lyse/fix method may be aided by an automated scoring approach. Image analysis software using a form factor parameter would allow the positive discrimination of round lymphocyte nuclei, thereby enriching their number in the analysed cell population ([@ref-19]). Here, TRI2 software was used to identify round cell nuclei and score foci automatically ([@ref-14]). [Figure 4](#fig-4){ref-type="fig"} shows the automated scoring results of 10 fields of view for each processing method and the two irradiation conditions. Automated foci counts are comparable for irradiated samples with averages of 3.49 ± 0.14 for lyse/fix and 3.76 ± 0.06 for histopaque (*p* = 0.84), but differ for baseline samples (0.16 ± 0.05 vs. 0.018 ± 0.004; *p* = 0.04). Foci counts for irradiated samples were always significantly higher than baseline counts (*p* \< 0.001). Importantly, ten times more scorable cells per field of view are seen with the histopaque protocol. The lyse/fix protocol produced 3 false negative fields out of 10 compared to 1 for the histopaque method, likely caused by high background fluorescence due to excessive debris in lyse/fix samples. These results suggest that if automated scoring were to be used to analyse samples, at least 2 (histopaque) and 3 (lyse/fix) fields of view need to be scored and results checked to ensure consistency. Further optimisation of the software may reduce the number of false negative fields.

![Comparison of automated *γ*-H2AX foci counts.\
Ten fields of view were analysed using Tri2 software ([@ref-2]) for each processing method and two irradiation conditions (0 or 1 Gy plus 1 h incubation at 37°C). Open triangles: 0 Gy + lyse/fix; solid triangles: 1 Gy + lyse/fix; open squares: 0 Gy + histopaque; solid squares: 1 Gy + histopaque.](peerj-02-282-g004){#fig-4}

To determine whether the rapid lyse/fix protocol can still provide dose estimates with similar accuracy as the routine histopaque protocol, an intercomparison exercise was performed using uniformly X-irradiated, coded samples. [Figure 5](#fig-5){ref-type="fig"} shows that the dose estimates obtained for the two different protocols correlated very well with each other (linear regression slope 1.03 ± 0.03; *R*^2^ = 99.5%). Linear regression of estimated versus true doses produced a slope of 0.87 ± 0.06 (*R*^2^ = 97.6%) for the histopaque method and 0.85 ± 0.05 (*R*^2^ = 98.3%) for the lyse/fix method. These results demonstrate excellent correlation between the two methods, but a modest systematic bias to under-estimate true doses, illustrating the need for frequent re-calibration of foci-based biodosimetry approaches to compensate any 'drift' in foci detection ([@ref-16]). Given the growing interest in point of care diagnostics, finger prick sampling of capillary blood has been widely tested and confirmed in numerous studies as a suitable alternative to venipuncture. Examples of such studies include a comparison of seroepidemiology of hepatitis B ([@ref-3]), CD4 cell counting ([@ref-10]) or differential leukocyte counting ([@ref-6]). We are not currently aware of any specific comparison of gamma-H2AX induction following irradiation but expect that results for capillary and venipuncture samples should be similar for this endpoint. One exception might be a scenario where blood is taken within seconds (or perhaps up to a few minutes) following a partial body exposure. In such a situation, blood lymphocytes in capillaries may not have had sufficient time to mix completely. However, this could only be of concern in studies where samples are taken immediately following a planned, very short and localised exposure, such as a CT scan ([@ref-13]). Naturally, the lyse/fix method presented here would also work with venipuncture samples where it would save blood, money and time that could then be used for other tests.

![Comparison of *γ*-H2AX dose estimates.\
Foci yields were determined for X-irradiated and 2 h incubated blood samples processed with the lyse/fix versus histopaque protocol. At least 50 cells or 200 foci were manually scored per coded sample. Foci yields were converted to dose estimates using calibration data from [@ref-7]. Actual doses were 0, 0.2, 0.6, 1.1, 1.2, 2.1 and 4.3 Gy. The line indicates the ideal 1:1 relationship.](peerj-02-282-g005){#fig-5}

Conclusion
==========

The lyse/fix protocol enables a high sample throughput, with an estimated processing time for 96 donors of just over 4 h, using finger prick-sized quantities of blood. This can be achieved by one person, without the need for highly sophisticated equipment. The manual microscope-based analysis of samples produced by the lyse/fix protocol is more challenging, which increases the scoring time, but has no adverse effect on dose estimation. Automated scoring may solve this problem but appears to be more prone to producing false-negative results for samples processed with the lyse/fix protocol compared to the histopaque method. Overall the rapid lyse/fix method allows one person to process and score 96 samples in about half the time taken using the routine protocol.

Supplemental Information
========================
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###### A rapid protocol for *γ*-H2AX processing

Detailed protocol for blood sample processing using the lyse/fix method for high throughput gamma-H2AX analysis.

###### 

Click here for additional data file.
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